Prof. Dr. Yong Song, MD, PhD

Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

Prof. Dr. Yong Song, MD, PhD, serves as a Professor and Director of the Department of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing University School of Medicine, China, where he also leads the Center of Lung Cancer at Jinling Hospital. Dr. Song received his Medical degree and PhD degree from Fourth Military Medical University and Third Military Medical University, in 1990 and 1998, respectively. From 2000 to 2002 and 2005 to 2007, he served as a Research Fellow at University of Colorado School of Medicine, Aurora, Colorado, USA. He is currently Editor-in-Chief for Translational Lung Cancer Research, and the Editorial Board of several professional journals, including the Journal of Thoracic Disease, Chinese Journal of Lung Cancer and Chinese Clinical Oncology. He has authored or coauthored more than 200 journal publications, abstracts, and book chapters.

Prof. Dr. Caicun Zhou, PhD, MD

Department of Oncology, Shanghai Pulmonary Hospital, Affiliated to Tongji University School of Medicine, Shanghai, China

Prof. Dr. Caicun Zhou, PhD, MD, is director of the Department of Oncology, Shanghai Pulmonary Hospital, director of Cancer Institute of Tongji University Medical School, chairman of the Oncology Department of Tongji University, He studied in Japan for two years and was a visiting scientist in USA for half a year. Professor Zhou is a committee member of the Chinese Association of Lung Cancer and the Chinese Society of Clinical Oncology, and is a council member of the Shanghai Anti-cancer Association, the Shanghai Pneumonology Association, and the Shanghai Oncology Association. He serves as a member on the editorial boards of many scientific journals, including ‘Tumor’, ‘Chinese-German Journal of Clinical Oncology’, ‘China Oncology’ and the ‘Chinese Journal of Clinical Oncology’ and also associate editor of Lung Cancer. Professor Zhou was selected as an ‘Excellent learning pioneer’ by the Science and Technology Commission of Shanghai Municipality (STCSM) in 2006, and got grants from the National 863 project and five other key research projects of the STCSM. His major research interests are in customized and targeted therapy of lung cancer, and he has published over 100 papers in scientific journals.

Prof. Rafael Rosell, MD, PhD

Director, Cancer Biology & Precision Medicine Program Catalan Institute of Oncology; Germans Trias i Pujol Health Sciences Institute and Hospital Badalona, Barcelona, Spain

Dr. Rafael Rosell is Head of the Medical Oncology Service and Scientific Director for Oncology at the Catalan Institute of Oncology, Hospital Germans Trias i Pujol (Badalona, Barcelona, Spain), Founder and Chief Scientific Director of Pangaea Biotech SA (Barcelona), Head of the Medical Oncology Service at USP Dexeus University Institute (Barcelona), and Professor at the Autonomous University of Barcelona. He is Founder and President of the Spanish Lung Cancer Group (SLCG) and a member of the Foundation Council and Steering Committee of the European Thoracic Oncology Platform (ETOP).

Dr. Rosell is a board member of the International Association for the Study of Lung Cancer (IASLC) and was Scientific Chair of their 2005 World Conference on Lung Cancer. He is a board member of many other international medical societies. He received a Certificate of Merit for his presentation at the Presidential Symposium on the occasion of the 31st ESMO Congress in 2006. In November 2006, he was named Professor Honoris Causa by the University of Cordoba in Argentina, and he was awarded the Silver Caravel award by the city of Bari, Italy in recognition of his work in lung cancer. In 2005, Dr. Rosell was awarded the Eminent Clinical Scholar in Residence at the Winship Cancer Institute of the Emory University School of Medicine in Georgia, USA. Dr Rosell has also been accredited in Advanced Research in the realm of Health & Medical Sciences by the Quality Agency of the Catalan University System.

He is the International Editor for Clinical Lung Cancer and he is on the Editorial Board of several professional journals, including Lung Cancer, Annals of Oncology, American Journal of Cancer, and Future Oncology. He is past president of the Asociación Espanola de Investigación sobre el Cancer (ASEICA) and past editor of Revista de Oncología, the official publication of five Spanish oncology societies. Dr. Rosell has authored over 500 articles published in peer-reviewed medical and scientific journals, and he has given more than 600 presentations at medical and scientific conferences around the world.